[瓦尔酸诱导的淋巴细胞结肠炎在儿童患者:一个案例报告]
Gustavo Javier Tagliaferro1, María Soledad Arcucci1, Verónica Beatriz Busoni1
1Médico gastroenterólogo pediatra. Hospital Italiano de Buenos Aires. Ciudad Autónoma de Buenos Aires, Argentina. Hospital Italiano de Buenos Aires Ciudad Autónoma de Buenos Aires Argentina.
Acta gastroenterologica Latinoamericana
|December 4, 2025
概括
微观性结肠炎,包括淋巴细胞性结肠炎,越来越多地被诊断出来. 一个儿科病例强调了酸作为潜在的触发因素,在药物停止后症状会消失.
科学领域:
- 胃肠病学 胃肠病学
- 组织病理学 组织病理学
- 儿科医学 儿科医学
背景情况:
- 微观性结肠炎呈现为慢性水性腹,内镜检查正常,但有明显的组织学发现.
- 原性结肠炎和淋巴细胞性结肠炎是微观性结肠炎的亚型.
- 虽然在历史上被认为是罕见的,但最近的数据显示,显微性结肠炎的患病率正在上升,通常与药物诱导或自身免疫因素有关.
研究的目的:
- 报告儿科病人的淋巴细胞性结肠炎病例.
- 为了研究烯酸在药物诱导的微观结肠炎中的潜在作用.
- 为了证明药物戒断后症状的消失.
主要方法:
- 一个儿科病人的病例报告.
- 临床观察症状和内镜检查结果.
- 结肠活检的组织病理学检查.
- 在停止使用瓦尔酸后,对症状的监测.
主要成果:
- 这位患者出现了慢性水性腹.
- 组织学检查证实了淋巴细胞性结肠炎.
- 在停止服用瓦尔酸后,症状完全消失.
- 停药后没有发现症状的复发.
结论:
- 瓦尔酸可能会诱导儿科患者的淋巴细胞性结肠炎.
- 药物诱导的微观结肠炎是一种可逆性疾病.
- 早期识别和撤销致病原体对于治疗至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
176
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
176
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
231
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
231
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
825
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
825
Pharmacokinetics in Pediatric Patients: Drug Excretion
195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
Pharmacokinetics in Pediatric Patients: Drug Distribution
244
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
244
Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450


